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Purpose: To investigate clinical implications of delta neutrophil index (DNI) to 
discriminate adult onset Still’s disease (AOSD) from sepsis. Materials and Meth-
ods: We reviewed the medical records of 13 patients with AOSD and 33 gender 
and age-matched patients with sepsis. In all subjects, microbial tests were per-
formed to exclude or confirm sepsis. All laboratory data were measured two or 
three times during the first 3 days and represented by their mean levels. DNI was 
measured automatically by ADVIA 2120 for the first 3 days. Results: There were 
no significant differences in white blood cell counts, neutrophil proportion, eryth-
rocyte sedimentation rate and C-reactive protein between two groups. AOSD pa-
tients had notably lower DNI than sepsis patients regardless of the presence of 
bacteremia or not. However, both DNI and ferritin were not significant indepen-
dent factors for predicting sepsis in the multivariate logistic regression analysis. 
Meanwhile, the area under the receiver operating characteristic curve (AUROC) 
of DNI was slightly higher than that of ferritin. When we set DNI of 2.75% as the 
cut-off value for predicting sepsis, 11 (84.6%) of AOSD patients had a DNI value 
below 2.75% and 2 (15.4%) of them had a DNI over 2.75% (relative risk for sep-
sis 176). Conclusion: We suggest that DNI may be a useful marker for differential 
diagnosis of AOSD from sepsis in the early phase as supplementary to ferritin.
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INTRODUCTION
Adult-onset Still’s disease (AOSD) is a systemic inflammatory disorder of unknown 
etiology.1 Several classification criteria for AOSD have so far been suggested, how-
ever, there are no objective laboratory tests for its diagnosis.2,3 Thus, diagnosis of 
AOSD is still based on heterogeneous clinical manifestations and laboratory results 
with exclusion of other febrile conditions.1 Especially in early phase, it is difficult to 
differentiate AOSD from infection due to their indistinguishable symptoms and labo-
ratory findings, such as fever and leukocytosis. In order to distinguish the two diseas-
es in early phase, several efforts have so far been made, however, a specific biomark-
er has not yet been established.4-6 Novel biomarkers that could represent the disease 
activities had been studied in other autoimmune inflammatory diseases.7 
Delta neutrophil index (DNI) is an automatically calculated parameter that re-
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CT scanning or echocardiography. Kidney involvement 
was also assessed and defined as hematuria >5 red blood 
cells per high-power field or proteinuria >500 mg more 
than twice per 24 h on urinalysis. Laboratory data including 
WBC count, erythrocyte sedimentation rate (ESR), CRP, 
and ferritin were measured two or three times during the 
first 3 days and represented by their mean levels. In all sub-
jects, microbial tests on blood, urine, sputum and sources 
suspected of infection were performed to confirm infectious 
disease.
Measurement of DNI 
DNI was calculated by an automatic cell analyzer (ADVIA 
2120 Hematology System, Siemens Healthcare Diagnostics, 
Forchheim, Germany) two or three times during the first 3 
days. DNI was calculated using the following formula: DNI= 
[the neutrophil sub fraction and the eosinophil sub fraction 
measured in the myleoperioxidase (MPO) channel by the 
cytochemical MPO reaction]-[the polymorphic neutrophils 
(PMN) sub fraction measured in the nuclear lobularity 
channel by the reflected light beam].8
Statistical analysis
Mean differences in continuous variables between two groups 
were evaluated using Mann-Whitney U test, and among 
three groups by Kluskal-Wallis test. A chi-squared test was 
applied to determine the gender distribution and frequen-
cies of clinical manifestations between the groups. Variables 
that had statistical significance (p-value <0.05) in univariate 
analysis were assessed using binary logistic regression to 
examine the odds ratio of DNI for predicting sepsis. Sensi-
tivity and specificity of the cut-off value related to DNI was 
set using the receiver operating characteristic (ROC) curve. 
Statistical analyses were performed using the SPSS for 
Windows software (version 18.0, SPSS Inc., Chicago, IL, 
USA). Comparison of area under the receiver operating 
characteristic curve (AUROC) was performed using Med-
Calc (version 12.3.0, Ostend, Belgium). In all analyses, p-
value <0.05 indicated statistical significance.
 
RESULTS
 
Clinical characteristics of patients with AOSD and 
those with sepsis
Clinical characteristics of all patients are described in Table 1. 
Mean age of AOSD patients (male 3, female 10) was 43.9± 
flects the ratio of immature granulocytes (IGs) over total neu-
trophil count in the peripheral circulation 8.8,9 IGs are hema-
tologic cells that do not reach full maturation of complete 
neutrophil nuclear lobulation,10 and are usually released to 
peripheral blood by catecholamines and pro-inflammatory 
cytokines in sepsis.11 DNI has been reported to be more pre-
dictive of sepsis severity and prognosis than traditional mark-
er including white blood cell (WBC) counts, absolute neutro-
phil counts and C-reactive protein (CRP).8,9,12,13 With these 
reasons, DNI may be considered useful for discriminating 
AOSD from sepsis, but its clinical application has not been 
reported to date. In this study, therefore, we investigated 
clinical implications of DNI for discriminating the two dis-
eases in early phase. 
MATERIALS AND METHODS
　　　
We retrospectively reviewed the medical records of 16 pa-
tients with AOSD with 19 episodes of fever at admission. 
They were admitted for fever at Yonsei University Medical 
Center from Jan 2010 to Mar 2012. Three patients were ex-
cluded because they had no febrile events at admission, and 
three episodes were excluded because microbial infections 
were confirmed through culture studies. All patients fulfilled 
Yamaguchi’s criteria for AOSD,3 and had febrile episode at 
admission. We also reviewed the medical records of 33 gen-
der- and age-matched patients who were admitted to the 
same institute during the same period, and who were diag-
nosed with sepsis, excluding hematologic disorder. Sepsis 
is defined as a systemic inflammatory response syndrome 
(SIRS) accompanied by proven microbial infection. SIRS 
was defined as two or more of the following conditions: 1) 
body temperature >38°C or <36°C; 2) leukocytosis >12000/
μL, leucopenia (<4000/μL); 3) heart rate >90 beats/min; 4) 
respiratory rate >24/min.8 Bacteremia was defined as the 
presence of microbial organisms in blood culture. This study 
was approved by the Institutional Review Board of Sever-
ance Hospital. 
Data collection
On the first day of hospitalization, physicians assessed clin-
ical manifestations, including fever, typical rash, arthralgia/
arthritis, lymphadenopathy, sore throat, and abdominal pain. 
Splenomegaly or hepatomegaly was evaluated by abdomi-
nal CT scanning or ultrasonography. Pleuritis, pericarditis 
and pneumonitis were confirmed by chest X-ray or chest 
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Eighteen (54.5%), 3 (9.1%), and 2 (6.1%) of sepsis patients 
had urinary tract infections, biliary infections and pneumo-
nia, respectively. Other infections included infective endo-
carditis (n=1), peritonitis (n=1) and cytomegalovirus (CMV) 
infection (n=1).
Univariate and multivariate analysis
There were no significant differences in WBC counts or 
neutrophil proportions between the two groups. AOSD pa-
13.4 years old and that of sepsis patients (male 8, female 25) 
was 48.8±11.0 years old. The most common clinical mani-
festation in AOSD patients was fever (100%), followed by 
arthralgia/arthritis (92.3%), typical rash (69.2%) and sore 
throat (61.5%). Lymphadenopathy, organomegaly and pleu-
ritis were also presented in patients with sepsis (21.2%, 
6.1%, and 15.2%). Fever was documented, and microbial 
organisms were confirmed in all patients with sepsis. Twen-
ty-four of 33 patients with sepsis (72.7%) had bacteremia. 
Table 1. Clinical Characteristics of Patients with AOSD and Those with Sepsis
Patients with AOSD Patients with sepsis p value
Sex (M/F) 3/10 8/25 0.628
Age 43.9±13.4 48.8±11.0 0.214
Fever (%) 13 (100) 33 (100)
Arthralgia/arthritis (%) 12 (92.3)   0 <0.001
Skin rash (%)   9 (69.2)   0 <0.001
Sore throat (%)   7 (53.8)   1 (3.0) <0.001
Lymphadenopathy (%)   4 (30.8)   7 (21.2) 0.467
Hepatomegaly/splenomegaly (%)   2 (15.4 )   2 (6.1) 0.338
Pericarditis (%)   1 (7.7)   0 <0.001
Pleuritis (%)   1 (7.7)   5 (15.2) 0.417
Bacteremia (%) - 24 (72.7)
Urinary tract infection (%) - 18 (54.5)
Biliary infection (%) -   3 (9.1)
Pneumonia (%) -   2 (6.1)
Other infection (%) -   3 (18.2)
AOSD, adult onset Still’s disease.
The number of patients with AOSD were 13 and that of patients with sepsis were 33. Biliary infection: confirmed microbial growth in bile through culture 
study. Values are expressed as the mean±standard deviation.  
Table 2. Laboratory Results between Patients with AOSD and Those with Sepsis in Univariate and Multivariate Analysis
Patients with AOSD Patients with sepsis p value OR* 95% CI p value
WBC count (/μL) 12329.2±4240.6 15793.9±6809.2 0.134
Neutrophil (%) 85.6±4.8 88.4±5.1 0.232 
Delta neutrophil index (%)   1.8±1.0   9.4±7.8 <0.001 1.982   0.386-10.164 0.412
ESR (mm/hr)   81.1±26.7   68.1±29.5 0.242
CRP (mg/L)   155.7±105.5   161.5±101.5 0.798
Creatinine (mg/dL)   0.9±0.3   1.3±1.4 0.526
AST (IU/L)   41.2±20.2   58.9±59.3 0.990
ALT (IU/L)   29.5±24.9   48.1±49.1 0.445
Total bilirubin (mg/dL)   0.5±0.2   2.4±3.9 0.010 0.649 0.094-4.470 0.661
Albumin (g/dL)   3.7±0.4   3.1±0.7 0.003 0.001   0.000-76.344 0.228
LDH (IU/L)   398.1±192.0   511.0±360.0 0.690
Ferritin (ng/mL)   5565.8±6536.8     891.5±1100.6 0.030 0.999 0.998-1.001 0.379
PT (INR)   1.1±0.1   1.2±0.3 0.940
aPTT (sec) 27.5±2.1   32.5±11.7 0.118 
WBC, white blood cell; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; 
LDH, lactate dehydrogenase; PT, prothrombin time; aPTT, activated partial thromboplastic time; CI, confidence interval; OR, odds ratio; AOSD, adult onset 
Still’s disease; DNI, delta neutrophil index; INR, international normalized ratio.
Continuous variables are expressed as mean±standard deviation, and compared by Mann-Whitney U test between the two groups. 
*Odds ratio for predicting sepsis by binary logistic regression analysis of DNI, ferritin, albumin and total bilirubin.
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CRP levels were not different between the two groups. Fer-
ritin levels in AOSD patients were elevated compared to sep-
sis patients (5565.8±6536.8 vs. 891.5±1100.6, p=0.030). 
Sepsis patients had lower albumin level and higher total bili-
rubin level than AOSD patients (Table 2). We performed a 
binary logistic regression analysis of these variables with sig-
nificant differences, and found that the usefulness of DNI did 
not surpass that of ferritin for differential diagnosis sepsis 
from AOSD (Table 2). Meanwhile, we compared AUROC 
of ferritin and the DNI, and found that AUROC of the DNI 
had slightly higher than that of ferritin, but difference of area 
was not statically significant [area under curve (AUC)=0.896 
vs. AUC= 0.769, p=0.68] (Fig. 1).
Sub-group analysis according to the presence of 
bacteremia
We further assigned sepsis patients to two sub-groups based 
on the presence of bacteremia. There were no significant 
differences in WBC counts and levels of ESR and CRP. 
However, AOSD patients had significantly lower DNI lev-
els than sepsis patients with and without bacteremia (1.8± 
tients had significantly lower mean DNI than sepsis pa-
tients (1.8±1.0% vs. 9.1±7.6%, p<0.001), while ESR and 
Fig. 1. Comparison of AUROC between delta neutrophil index (DNI) and fer-
ritin. AUC of DNI was slightly higher than that of ferritin [0.896 (p<0.001) vs. 
0.769 (p=0.008), respectively]. However, difference between the areas of 
DNI and ferritin was 0.0538, not statistically significant (p=0.68). AUC, area 
under curve. 
AUC Standard error
95% confidential 
interval p value
DNI 0.896 0.046 0.771-0.967 <0.001
Ferritin 0.769 0.101 0.548-0.917   0.008
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Fig. 2. Sub-group analysis according to the presence of bacteremia. Patients in sepsis group were divided into 10 patients of sepsis without bacteremia 
group and 27 patients of sepsis with bacteremia group. The levels of WBC count (A), CRP (C) and ESR (D) had no difference between three groups. The delta 
neutrophil index (B) had significant difference in AOSD, non-bacteremia and bacteremia group (1.8±1.0 vs. 7.9±3.7 vs. 9.9±8.9, p<0.001 respectively). WBC, 
white blood cell; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; AOSD, adult onset Still’s disease.
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tinemia has been suggested as a most useful marker of 
AOSD,6 and hyperferritinemia with low glycosylated ferri-
tin had been reported as a more powerful marker. However, 
they were also insufficient to differentiate AOSD from sep-
sis because elevated ferritin was often observed in other in-
flammatory diseases including sepsis and it might not be el-
evated in the early phase of AOSD.19 Fautrel, et al.20 could 
not show significant differences of hyperferritinemia with 
low glycosylated ferritin between AOSD and infection. Pre-
vious study suggested that only clinical manifestation could 
differentiate AOSD from sepsis.4 We compared clinical 
characteristics between two groups and clinical manifesta-
tions, including typical rash and arthralgia, could differenti-
ate between two diseases, but nonspecific symptoms such as 
lymphadenopathy were often present in patients with sepsis 
in this study.
Thus, a useful serologic marker is needed to discriminate 
AOSD from sepsis. We introduced a novel value, DNI for the 
differential diagnosis of AOSD from sepsis. In the present 
study, we first verified that DNI in AOSD was significantly 
lower than in sepsis. One of typical feature of AOSD is leuko-
cytosis with neutrophilia, which was similar to sepsis. The 
mechanism of leukocytosis remains uncertain although a pre-
vious study reported that granulocyte hyperplasia is found in 
the bone marrow of AOSD patients.21 However, over 80% of 
neutrophil are mature PMN in AOSD,18 which might be re-
sponsible for our results. 
Previous studies showed that DNI was early prognostic 
1.0% vs. 9.9±8.9%, p=0.001 and 1.8±1.0% vs. 7.9±3.7%, 
respectively) (Fig. 2). 
The cut-off value of DNI for differential diagnosis of 
sepsis from AOSD
We used AUROC to identify the optimal cut-off value of 
DNI for predicting sepsis in order to make differential diag-
nosis from AOSD. Thus, we selected a DNI of 2.75% as 
the cut-off value to maximize sensitivity (82.1%) and speci-
ficity (84.6%). In AOSD patients, 11 (84.6%) had a DNI 
value below 2.75% and 2 (15.4%) had a DNI over 2.75%. 
In contrast, only 1 sepsis patient (3.0%) had a DNI below 
2.75%, while the remainder (97.0%) had a DNI value over 
2.75%. And the relative risk for sepsis was 176.0 (95% 
confidential interval 14.501-2136.176) (Fig. 3).
DISCUSSION
AOSD is generally a mild and self-limiting disease, and it 
could progress to a chronic course with relapse and occa-
sional life-threatening complications in one-third of patients. 
Kim, et al.14 indicated that short diagnostic delay was a 
good prognostic factor as a result of effective treatment, and 
response to glucocorticoid therapy was also an important 
prognostic factor. Moreover, mortality rate of AOSD was 
9-10%, and main cause of death was sepsis, pneumonia and 
disease progression.14-16 Especially in sepsis, early recogni-
tion and early antibiotics therapy within the first six hours 
significantly decreased in-hospital mortality.17 Therefore, 
early differential diagnosis AOSD from sepsis might be a 
crucial for leading to a good prognosis.14,17,18 Nonetheless, 
in the clinical settings, and from the clinical point of view, 
there are several difficulties as follows: 1) it is difficult to 
distinguish between AOSD and sepsis in the early phase be-
fore the report on the results of culture studies; 2) treatment 
strategies are different between the two diseases; and 3) the 
long incubation period of culture studies hinders a rapid fi-
nal diagnosis.
Several biomarkers for the differential diagnosis of the 
two diseases have so far been suggested, but definite bio-
marker had not yet been established clinically. Calprotectin 
produced by monocytes could not distinguish AOSD from 
microbial infection, despite good correlations with AOSD 
activity.4,5 And serum levels of cytokines involved in patho-
physiology of AOSD did not show significant differences 
between the two diseases either.4 In addition, hyperferri-
Fig. 3. Proportion of patients with AOSD and sepsis according to delta neu-
trophil index. Patients in two groups were divided according to cut-off val-
ue of DNI, 2.75%. In patients with AOSD, 11 patients (84.6%) had DNI below 
2.75% and 2 patients (15.4%) had DNI over 2.75%. In patients with sepsis, 1 
patient (3.0%) had DNI below 2.75% and the rest of them (97.0%) showed 
DNI over 2.75% (p<0.001). AOSD, adult onset Still’s disease; DNI, delta neu-
trophil index.
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between AOSD and sepsis that have relatively high sensi-
tivity and specificity. Also, DNI is included in the complete 
blood count test, which is routinely performed without addi-
tional costs or tests when patients with fever are admitted to 
a hospital. Considering that there are only a few objective 
laboratory results to help physicians to discriminate AOSD 
and sepsis in their early phase, DNI can be a raid and effi-
cious marker for it. Consequently, we suggest that DNI 
might be useful to differentiate AOSD from sepsis as a sup-
plementary variable to ferritin, although DNI could not be 
an independent predictive value for differential diagnosis 
between the two diseases. 
This study has two limitations: first, small number of 
AOSD patients was enrolled in the study due to its rare in-
cidence, and second, other biomarkers such as procalcito-
nin or calprotectin were not analyzed. If future study in-
cludes larger number of AOSD patients and measure these 
biomarkers together, it might reveal a dynamic role for dif-
ferential diagnosis of AOSD from sepsis in early phase.  
In conclusion, we suggest that DNI might be a useful 
marker for differential diagnosis between AOSD from sep-
sis at an early phase of the two diseases when their disease 
patterns are indistinguishable. 
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